We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (17)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1046 result(s) found, displaying 901 to 925
-
Safety alertsThe Therapeutic Goods Administration (TGA) has taken steps today to quarantine CSL Human Albumin solutions from further use while an assessment is undertaken of the safety of these products.
-
Safety alerts
-
Safety alertsWe are updating safety information for statins due to potential risks like memory loss and increased blood sugar levels. Consult your doctor if you have concerns.
-
Safety alertsPoly Implant Prothèse (PIP) update
-
Safety alertsTGA has increased the number of samples of PIP breast implants tested for shell integrity
-
Market actionsInformation on the management of issues related to the recall of PIP silicone gel breast implants
-
Market actionsInformation on the management of issues related to the recall of PIP silicone gel breast implants
-
Safety alertsCounterfeit Avastin injections found in the USA do not have the active ingredient. We've reminded health professionals that importing or supplying counterfeit medicines in Australia is illegal.
-
Safety alerts
-
Safety alertsPoly Implant Prothèse (PIP) update
-
-
Safety alertsPIP breast implants were available in Australia between 1998 and April 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace following reports of increased risk of rupture with PIP breast implants as a result of use by the manufacturer of non-approved silicone gel.
-
-
Safety alerts
-
Safety alerts
-
Market actionsThe TGA advises that while PIP breast implants were recalled due to the use of unauthorised silicone, current evidence does not support routine removal in patients without symptoms, and individuals are encouraged to seek medical advice if concerned.
-
Market actionsAt the time of writing, the TGA has been advised that approximately 9,054 PIP breast implants have been implanted by surgeons between 2002 and 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace.
-
Safety alertsUpdated recommendations for Pneumovax 23 revaccination due to high rates of local reactions after repeat doses.
-
Safety alerts
-
Safety alerts
-
Safety alertsWe are updating safety information for Simvastatin due to new contraindications, precautions, and dosage recommendations. Consult your doctor if you have concerns.
-
Market actions
-
Market actionsSpecific packs (lots) of Avaira Sphere contact lenses are being recalled by CooperVision Australia Pty Ltd
-
-
Safety alerts